Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 04, 2025 UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics(R), Triclonics(R) and ADClonics(R)), today announced that […]

Dorman Products, Inc. Reports Second Quarter 2025 Results and Raises Full Year 2025 Guidance

Dorman Products, Inc. Reports Second Quarter 2025 Results and Raises Full Year 2025 Guidance GlobeNewswire August 04, 2025 Highlights (All comparisons are to the prior year period unless otherwise noted): Net sales of $541.0 million for the quarter, up 7.6% compared to $503.0 million Diluted earnings per share (“EPS”) of $1.91, up 25% compared to

Agios’ PYRUKYND(R) (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia

Agios' PYRUKYND(R) (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia GlobeNewswire August 04, 2025 First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA's Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage PYRUKYND commercialization in the Gulf Region

US WorldMeds Completes Acquisition of Adaptimmune’s Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel

US WorldMeds (USWM) reported the successful closing of the previously announced acquisition of Adaptimmune Therapeutics plc's (Adaptimmune) cell-therapy assets-including TECELRA® (afamitresgene autoleucel), lete-cel, afami-cel, and uza-cel. The acquisition was first announced on July28, 2025and has now been finalized. Under the terms of the Asset Purchase Agreement, USWM paid $55 million in cash at closing and

ResCap Liquidating Trust Announces Posting of Q2 2025 Financial Statements

TheResCap Liquidating Trust (the “Trust”) announced its unaudited Consolidated Financial Statements, as of and for the period ended June 30, 2025, along with its quarter-end Beneficiary Letter and tax letter. These documents will be filed with the courts and posted to the Verita Global website at https://www.veritaglobal.net/rescap https://mma.prnewswire.com/media/2743801/Q2_2025_Beneficiary_Letter__ID_e302913aac28.pdf?p=pdfthumbnail https://mma.prnewswire.com/media/2743796/Q2_2025_Financial_Statements__ID_4732ae7bbc92.pdf?p=pdfthumbnail https://mma.prnewswire.com/media/2743800/Q2_2025_Tax_Letter__ID_ab30ad2cddfc.pdf?p=pdfthumbnail https://c212.net/c/img/favicon.png?sn=CG43857&sd=2025-08-04 View original content to

Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd

(NasdaqGM:RXST), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the securities of RxSight, Inc. (NASDAQ: RXST) (“RxSight” or the “Company”). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT

BayFirst Discontinues Bolt SBA 7(a) Loan Program

(NASDAQ:BAFN), ST. PETERSBURG, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or “Company”), parent company of BayFirst National Bank (“Bank”) today announced that as part of a comprehensive strategic review aimed at positioning the Company for long-term growth and enhanced shareholder value, the Bank has discontinued its Bolt loan program,

FLYW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Flywire Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NASDAQ:FLYW), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Flywire Corporation (“Flywire” or “the Company”) (NASDAQ: FLYW) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

LMT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lockheed Martin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NYSE:LMT), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lockheed Martin Corporation (“Lockheed Martin” or “the Company”) (NYSE: LMT) and certain of its officers. Class Definition This lawsuit seeks to recover

SOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sable Offshore Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

(NYSE:SOC), NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sable Offshore Corp. (“Sable” or “the Company”) (NYSE: SOC) and certain of its officers. Class Definition This lawsuit seeks to recover damages

Scroll to Top